Skip to main content
Home

Epocrates Online Contact us

  • Explore features
  • Reach clinicians
  • Buy now
By vgreene, 1 July, 2021

cabozantinib

By vgreene, 1 July, 2021

bevacizumab and its biosimilars bevacizumab awwb bevacizumab bvzr

By vgreene, 1 July, 2021

axitinib

By vgreene, 1 July, 2021

View epocrates drug info

By vgreene, 1 July, 2021

asymptomatic pts add Holter ECG monitoring for AF screening

By vgreene, 1 July, 2021

Perform cardio oncological f u eval on parameters listed above q3mo for 1y then q6mo throughout ibrutinib tx

By vgreene, 1 July, 2021

Use the same imaging modality for monitoring

By vgreene, 1 July, 2021

CMR imaging recommended if the quality of TTE suboptimal

By vgreene, 1 July, 2021

LV contrast agents could be potentially useful in 2 D echocardiography

By vgreene, 1 July, 2021

Monitoring During Tx 1

Pagination

  • First page
  • Previous page
  • …
  • Page 1028
  • Page 1029
  • Page 1030
  • Page 1031
  • Current page 1032
  • Page 1033
  • Page 1034
  • Page 1035
  • Page 1036
  • …
  • Next page
  • Last page

About Us

  • Company Overview
  • Media Relations
  • Contact
  • Editorial Policy
  • Editorial Process
  • Third-Party Sponsorship Policy
  • athenahealth

Products

  • Core Products
  • Mobile CME
  • Product Licenses

Business Solutions

  • Pharma
  • Market Research
  • Institutions

Support

  • Support Center
  • Install
  • My Account

Stay Connected

Facebook Twitter YouTube

Patient Resource Footer Bottom

  • Privacy Policy
  • Terms of Use
  • Site Map